KCIF Co-Investment Fund KB, 10% Owner at Aprea Therapeutics, Inc. (APRE), sold 483,406 shares at $34.55 ($16.7M) on 2020-07-07, disclosed to the SEC on 2020-07-07.
Open-market sale of $16.7M APRE by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.55 | 241,703 | $8.4M | 50.0% |
| 2 | $34.55 | 241,703 | $8.4M | 50.0% |
| Total | $34.55 avg | 483,406 | $16.7M | 100% |